Solid Biosciences Inc.
Solid Biosciences Inc.（SLDB）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
sldb · 股价预测 · 21 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 21 位华尔街分析师
Buy
21 位分析师
共识
评级分布
12 个月目标价
High
$18.00
Consensus
$17.00
+165.2% upside
Low
$16.00
Median: $17 · Last Close: $6.41
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$17.00
165.2% upside
High Target
$18
180.8%
Low Target
$16
149.6%
Current Price
$6.41
as of today
Based on analyst price targets, the SLDB stock price prediction for the next 12 months ranges from $16 to $18. The consensus SLDB price forecast of $17.00 implies 165.2% upside from the current price of $6.41.
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $6.29 | ↓ 1.84% |
1-day model range: $6.24–$6.34. Peak: $6.34 (-1.84%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $5 | -27.7% |
| 2028 | $4 | -38.7% |
| 2029 | $4 | -43.8% |
| 2030 | $3 | -46.4% |
| 2031 | — | -47.8% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · SLDB · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-06-03 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-05-18 | Wedbush | Maintains | Outperform→Outperform |
| 2026-05-13 | Wedbush | Maintains | Outperform→Outperform |
| 2026-05-13 | Piper Sandler | Maintains | Overweight→Overweight |
| 2026-03-25 | JP Morgan | Maintains | Overweight→Overweight |
| 2026-03-23 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-03-20 | Needham | Maintains | Buy→Buy |
| 2026-03-20 | Chardan Capital | Maintains | Buy→Buy |
| 2026-03-12 | Wedbush | Maintains | Outperform→Outperform |
| 2026-03-12 | Chardan Capital | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Solid Biosciences Inc. (SLDB) stock. Of the recent 94 rating actions, 9 were upgrades and 6 were downgrades. 21 analysts currently cover SLDB.
分析师推荐趋势
SLDB analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 4 to 1 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$4M
↓ 97.1% YoY
Revenue Next Year
$13M
↑ 261.4% YoY
EPS This Year
$-1.93
EPS Next Year
$-1.93
↓ 0.2% YoY
EPS ForecastReported vs Estimated
Analysts forecast SLDB EPS of $-1.93 for the current fiscal year, based on estimates from 10 analysts. The SLDB revenue forecast is $4M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
SLDB 股价预测由两类独立数据源支撑：来自 21 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。SLDB 的共识目标价为 $17.00（+165.2% 上行空间），分析师共识为 Buy。
SLDB 的短期预测（明日）为 $6.29（-1.84%）。 SLDB 对 2027 年的股价预测均值为 $5。 SLDB 对 2030 年的预测区间为 $3–$4。
Solid Biosciences Inc. 在 NASDAQ 上市，代码 SLDB。SLDB 在 2027 年的整体展望偏积极，在覆盖分析师中约 76% 对应 Buy 共识。
常见问题
SLDB 预测 · 8 个问题根据 21 位华尔街分析师，SLDB 的 12 个月平均目标价为 $17.00，最高 $18.00、最低 $16.00。若有图表，中位目标价可在上方查看。相对当前价 $6.41，隐含约 +165.2% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.